These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37298687)

  • 21. Targeted Metabolomic Analysis in Alzheimer's Disease Plasma and Brain Tissue in Non-Hispanic Whites.
    Kalecký K; German DC; Montillo AA; Bottiglieri T
    J Alzheimers Dis; 2022; 86(4):1875-1895. PubMed ID: 35253754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum metabolomic profiling in patients with Alzheimer disease and amnestic mild cognitive impairment by GC/MS.
    Sun C; Gao M; Wang F; Yun Y; Sun Q; Guo R; Yan C; Sun X; Li Y
    Biomed Chromatogr; 2020 Sep; 34(9):e4875. PubMed ID: 32384189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovering Hair Biomarkers of Alzheimer's Disease Using High Resolution Mass Spectrometry-Based Untargeted Metabolomics.
    Su YH; Chang CW; Hsu JY; Li SW; Sung PS; Wang RH; Wu CH; Liao PC
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary Metabolomics Reveals Alterations of Aromatic Amino Acid Metabolism of Alzheimer's Disease in the Transgenic CRND8 Mice.
    Tang Z; Liu L; Li Y; Dong J; Li M; Huang J; Lin S; Cai Z
    Curr Alzheimer Res; 2016; 13(7):764-76. PubMed ID: 26825095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
    Gu Y; Zang P; Li J; Yan Y; Wang J
    Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients.
    Tsuruoka M; Hara J; Hirayama A; Sugimoto M; Soga T; Shankle WR; Tomita M
    Electrophoresis; 2013 Oct; 34(19):2865-72. PubMed ID: 23857558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related alterations in the metabolic profile in the hippocampus of the senescence-accelerated mouse prone 8: a spontaneous Alzheimer's disease mouse model.
    Wang H; Lian K; Han B; Wang Y; Kuo SH; Geng Y; Qiang J; Sun M; Wang M
    J Alzheimers Dis; 2014; 39(4):841-8. PubMed ID: 24284365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.
    Han X; Rozen S; Boyle SH; Hellegers C; Cheng H; Burke JR; Welsh-Bohmer KA; Doraiswamy PM; Kaddurah-Daouk R
    PLoS One; 2011; 6(7):e21643. PubMed ID: 21779331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathway-based integration of multi-omics data reveals lipidomics alterations validated in an Alzheimer's disease mouse model and risk loci carriers.
    Garcia-Segura ME; Durainayagam BR; Liggi S; Graça G; Jimenez B; Dehghan A; Tzoulaki I; Karaman I; Elliott P; Griffin JL
    J Neurochem; 2023 Jan; 164(1):57-76. PubMed ID: 36326588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular insights into sex-specific metabolic alterations in Alzheimer's mouse brain using multi-omics approach.
    Strefeler A; Jan M; Quadroni M; Teav T; Rosenberg N; Chatton JY; Guex N; Gallart-Ayala H; Ivanisevic J
    Alzheimers Res Ther; 2023 Jan; 15(1):8. PubMed ID: 36624525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolomic investigation of systemic manifestations associated with Alzheimer's disease in the APP/PS1 transgenic mouse model.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Mol Biosyst; 2015 Sep; 11(9):2429-40. PubMed ID: 26131452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
    Peña-Bautista C; Roca M; Hervás D; Cuevas A; López-Cuevas R; Vento M; Baquero M; García-Blanco A; Cháfer-Pericás C
    J Proteomics; 2019 May; 200():144-152. PubMed ID: 30978462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
    Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted and Untargeted Mass Spectrometry Reveals the Impact of High-Fat Diet on Peripheral Amino Acid Regulation in a Mouse Model of Alzheimer's Disease.
    Taylor AL; Davis DE; Codreanu SG; Harrison FE; Sherrod SD; McLean JA
    J Proteome Res; 2021 Sep; 20(9):4405-4414. PubMed ID: 34382806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted metabolomics study of early pathological features in hippocampus of triple transgenic Alzheimer's disease male mice.
    Zhao Y; Chen H; Iqbal J; Liu X; Zhang H; Xiao S; Jin N; Yao F; Shen L
    J Neurosci Res; 2021 Mar; 99(3):927-946. PubMed ID: 33197957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry.
    González-Domínguez R; García A; García-Barrera T; Barbas C; Gómez-Ariza JL
    Electrophoresis; 2014 Dec; 35(23):3321-30. PubMed ID: 25136972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lipid metabolomic analysis in exosomes of osteonecrosis of the femoral head based on ultra performance liquid chromatography-tandem mass spectrometry].
    Guo M; Zhang J
    Se Pu; 2022 Feb; 40(2):123-129. PubMed ID: 35080158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer's disease.
    Gross TJ; Doran E; Cheema AK; Head E; Lott IT; Mapstone M
    Dev Neurobiol; 2019 Jul; 79(7):622-638. PubMed ID: 31419370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A metabolomic study based on accurate mass and isotopic fine structures by dual mode combined-FT-ICR-MS to explore the effects of Rhodiola crenulata extract on Alzheimer disease in rats.
    Zhang X; Jiang X; Wang X; Zhao Y; Jia L; Chen F; Yin R; Han F
    J Pharm Biomed Anal; 2019 Mar; 166():347-356. PubMed ID: 30690248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolomic Signatures of Alzheimer's Disease Indicate Brain Region-Specific Neurodegenerative Progression.
    Ambeskovic M; Hopkins G; Hoover T; Joseph JT; Montina T; Metz GAS
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.